UKTN | The Podcast podcast

Producing drugs in outer space – Katie King, BioOrbit

0:00
30:18
Retroceder 15 segundos
Avanzar 15 segundos

Katie King, co-founder and chief executive of BioOrbit, discusses how her company is building pharmaceutical manufacturing facilities designed to operate in space and why that could fundamentally transform how the production of medicine works. 

BioOrbit is a British space tech company that aims to use the irreplicable conditions of outer space to improve the development of drugs that could massively shape how humans treat some of Earth’s most dangerous conditions. 

Otros episodios de "UKTN | The Podcast"